University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
NCT Number: NCT05979688
The aim of this study is to understand how well a 6-week virtual yogic breathing exercise program (YBEP) will improve breathing, speech, and emotional well-being in people with amyotrophic lateral sclerosis (ALS).
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Birmingham, Alabama, 35294, United States
The study will employ a RCT to test the two hypotheses. The study will incorporate a 2 x 2 two-way factorial design with repeated measures at three time points. The two between-subject factor conditions will be participation in a yogic breathing exercise program (YBEP) versus a waitlist control condition that will be evaluated at baseline, and immediately post-program. Thirty adults with ALS will be recruited for this study.
Hypothesis #1: Adults with ALS who participate in a YBEP will demonstrate improvement in breathing, and emotional well-being compared to waitlist controls at the conclusion of a 6-week YBEP.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A typical session will begin with the yoga instructor demonstrating a breathing exercise technique. The participants will learn and practice each technique.
Time frame: baseline
ALS Specific Quality of Life-Revised (ALSSQOL-R) consists of 6 subscales: negative emotion (13 items), interaction with people and the environment (11 items), intimacy (7 items), religiosity (4 items), physical symptoms (6 items), and bulbar function (5 items). The scale has 46 items rated on a 11-point Likert-type scale (0 to 10) with higher scores indicating better quality of life. Some items require reverse scoring.
Time frame: at 6 weeks
ALS Specific Quality of Life-Revised (ALSSQOL-R) consists of 6 subscales: negative emotion (13 items), interaction with people and the environment (11 items), intimacy (7 items), religiosity (4 items), physical symptoms (6 items), and bulbar function (5 items). The scale has 46 items rated on a 11-point Likert-type scale (0 to 10) with higher scores indicating better quality of life. Some items require reverse scoring.
University of Alabama at Birmingham
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05945784
Amyotrophic Lateral Sclerosis, Autoimmune Diseases
Pomona, California, United States
View Trial DetailsNCT07478172
Amyotrophic Lateral Sclerosis, Autoimmune Diseases
Columbia, Missouri, United States
View Trial DetailsNCT06605612
Amyotrophic Lateral Sclerosis, Autoimmune Diseases
München, Bavaria, Germany
View Trial DetailsNCT06539169
Alpha-Thalassemia, Alzheimer Disease
Los Altos, California, United States
View Trial Details